UCSF begins study testing antiviral drug tenofovir to prevent HIV infection
UCSF researchers have been funded by the National Institutes of Health to study the antiretroviral drug tenofovir as a potential pre-exposure prophylaxis in Cambodia among high-risk, HIV-uninfected women.